Document is current

Any future updates will be listed below

Mit Mepolizumab als Add-on-Therapie Exazerbationen reduzieren

Crossref DOI link: https://doi.org/10.1007/s15033-025-4213-0

Published Online: 2025-09-05

Published Print: 2025-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark